← Leaderboards
Alik Farber
Brigham And Women'S Hospital
$2,704,970
Attributed
$7,978,194
Total exposure
3
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.8M · FY2013–25$2M$1.5M$1M$500K$0
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$7,978,194 · 3
By mechanism
U01$6,121,533 · 1
R01$1,583,229 · 1
T32$273,432 · 1
Top collaborators
- Matthew Thomas Menard5 shared
- Kenneth Rosenfield5 shared
- Vipul C Chitalia2 shared
- Suvranu Ganguli2 shared
- Daniel G. Remick1 shared
Most similar at Brigham And Women'S Hospital
Same institution · by research overlap
- Michael Salvatore Conte$9,171,065
- Joshua A Beckman$4,886,792
- Daniel I Simon$14,441,938
- Niteesh K Choudhry$10,267,534
- Eva S Schernhammer$12,735,461
Others in their field
Top investigators on “Hemodynamics”
- Alan Jasanoff · Massachusetts Institute Of Technology$22,516,687
- Jay D Humphrey · Yale University$22,350,674
- Angela L. Jefferson · Vanderbilt University Medical Center$21,651,697
- Robert Freedman · University Of Colorado Denver$20,038,696
- Danny Bluestein · State University New York Stony Brook$18,226,851
- Kent A Kiehl · Hartford Hospital$17,001,778
Research focus
HemodynamicsSurgeonBlood VesselsIndexingRadiologistSafetyProceduresCost EffectiveComparative EffectivenessCost EffectivenessClinical CareCommunitiesAnkleCostClinical DataCessation Of LifeClinical Trials DesignAgingBaseBostonBypassCanadaAmputationAcademic Medical Centers
Grant awards (8)
Role of Intravenous ultrasound (IVUS) in arteriovenous hemodialysis access dysfunction$773,634
R01 · FY2025 · DK
Impact of Biological, Clinical, and Social Determinants on Trauma and Trauma Outcomes$273,432
T32 · FY2025 · GM · contact PI
Role of Intravenous ultrasound (IVUS) in arteriovenous hemodialysis access dysfunction$809,595
R01 · FY2024 · DK
BEST-CLI Trial-CCC-Lead$1,838,598
U01 · FY2018 · HL
BEST-CLI Trial-CCC-Lead$1,233,529
U01 · FY2017 · HL
BEST-CLI Trial-CCC-Lead$634,074
U01 · FY2016 · HL
BEST-CLI Trial-CCC-Lead$1,214,396
U01 · FY2015 · HL
BEST-CLI Trial-CCC-Lead$1,200,936
U01 · FY2013 · HL